Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4518432
Max Phase: Preclinical
Molecular Formula: C28H27NO4
Molecular Weight: 441.53
Molecule Type: Unknown
Associated Items:
ID: ALA4518432
Max Phase: Preclinical
Molecular Formula: C28H27NO4
Molecular Weight: 441.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(Nc1ccccc1Oc1ccc(C(C)O)cc1)=C1C(=O)CC(c2ccccc2)CC1=O
Standard InChI: InChI=1S/C28H27NO4/c1-18(28-25(31)16-22(17-26(28)32)21-8-4-3-5-9-21)29-24-10-6-7-11-27(24)33-23-14-12-20(13-15-23)19(2)30/h3-15,19,22,29-30H,16-17H2,1-2H3/b28-18-
Standard InChI Key: RHNIEYPBNVZJMF-VEILYXNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 441.53 | Molecular Weight (Monoisotopic): 441.1940 | AlogP: 5.93 | #Rotatable Bonds: 6 |
Polar Surface Area: 75.63 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.74 | CX Basic pKa: | CX LogP: 4.76 | CX LogD: 4.76 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.37 | Np Likeness Score: -0.41 |
1. Bueno O, Gargantilla M, Estévez-Gallego J, Martins S, Díaz JF, Camarasa MJ, Liekens S, Pérez-Pérez MJ, Priego EM.. (2019) Diphenyl ether derivatives occupy the expanded binding site of cyclohexanedione compounds at the colchicine site in tubulin by movement of the αT5 loop., 171 [PMID:30921759] [10.1016/j.ejmech.2019.03.045] |
Source(1):